ArticleAnnals of internal medicine2025

Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in People Living With Severe Hemophilia A : A Cost-Effectiveness Analysis.

Satoko Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.